About 11 results found for searched term "50-57-7" (0.053 seconds)
Cat.No. | Name | Target |
---|---|---|
M1777 | SGX523 | c-Met |
SGX-523 | ||
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. | ||
M4295 | Tenacissoside-X | Others |
Tenacissoside-X | ||
M8112 | PF-05085727 | Others |
PF-05085727 is a potent inhibitor against cGMP-dependent phosphodiesterase PDE2 (PDE2A; IC50 = 2. | ||
M11158 | Cyclo(-RGDfK) TFA | Integrin |
Cyclo(-RGDfK) TFA is a potent, selective integrin αvβ3 INHIBITORS, THEIR IC50 The value is 0.94 nM. Cyclo(-RGDfK) TFA specifically targets tumor microvascular and cancer cells by binding to αvβ3 integrins on the cell surface. | ||
M20343 | WAY-299359 | FLT3 |
WAY-299359 is a FLT3 inhibitor | ||
M21533 | BI-0474 | Ras |
BI-0474 is a covalent KRASG12C inhibitor. The IC50 value for GDP-KRAS::SOS1 protein-protein interaction was 7.0 nM. BI-0474 also showed better antitumor activity in non-small cell lung cancer xenograft models. | ||
M25195 | Efprezimod alfa | Others |
Efprezimod alfa is an active peptide. Efprezimod alfa can be used for various biochemical studies. | ||
M29337 | ARN19874 | Phospholipase |
ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM. | ||
M30203 | Lysipressin | Adenylate Cyclase |
Lysine vasopressin; [Lys8]-Vasopressin | ||
Lysipressin (Lysine vasopressin) is antidiuretic hormone that have been found in pigs and some marsupial families. Lysipressin induces contraction of the rabbit urinary bladder smooth muscle, activate adenylate-cyclase. | ||
M51744 | H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe | Others |
H-Phe-Gly-His-p-nitro-Phe-Phe-Ala-Phe-OMe is a polypeptide that can be hydrolyzed by Rennin. | ||
M52171 | (S)-3-Amino-4-hydroxybutanoic acid | Amino Acid Derivatives |
(S)-3-Amino-4-hydroxybutanoic acid is a serine derivative. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.